<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Morphologic <z:mpath ids='MPATH_589'>dysplasia</z:mpath> remains the criterion standard of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk in <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> but poses many challenges including distinction from reactive inflammatory change </plain></SENT>
<SENT sid="1" pm="."><plain>Gastric foveolar <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, a newly described subtype comprising 15% to 20% of Barrett <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, overlaps with reactive cardiac mucosa in <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Despite the clinical importance of accurate distinction, the issue has not been studied </plain></SENT>
<SENT sid="3" pm="."><plain>Review of 3698 biopsies from 461 Barrett patients yielded 160 biopsies with Barrett gastric foveolar <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (74 low grade and 86 high grade) </plain></SENT>
<SENT sid="4" pm="."><plain>These were compared with inflamed cardia from 80 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Immunohistochemistry was performed for Lgl2, MUC2, MUC5AC, and MUC6 </plain></SENT>
<SENT sid="6" pm="."><plain>Comparing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> with Barrett gastric foveolar <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, surface nuclear stratification (85% versus 0%, P &lt; .00001), upper mucosa-limited atypia (80% versus 0%, P &lt; .0001), villiform architecture (52% versus 4%; P &lt; .0001), full-thickness mucosal atypia (0% versus 100%, P &lt; .00001), and crowded glandular architecture (0% versus 75%, P &lt; .00001) <z:hpo ids='HP_0000001'>all</z:hpo> proved useful </plain></SENT>
<SENT sid="7" pm="."><plain>Cytologic features were less helpful </plain></SENT>
<SENT sid="8" pm="."><plain>Comparing low-grade gastric <z:mpath ids='MPATH_589'>dysplasia</z:mpath> alone, because its distinction from reactive cardia may be even more challenging, the listed features <z:hpo ids='HP_0000001'>all</z:hpo> remained significant </plain></SENT>
<SENT sid="9" pm="."><plain>Loss or aberrant Lgl2 expression was much more typical of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (12% versus 99%; P = .0001) </plain></SENT>
<SENT sid="10" pm="."><plain>MUC proteins did not distinguish the groups </plain></SENT>
<SENT sid="11" pm="."><plain>Surface nuclear stratification, "top-heavy" atypia, and noncrowded, villiform architecture were highly characteristic of reactive cardiac atypia in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, in comparison with the monolayered nuclei in crowded glands occupying the full mucosal thickness in Barrett gastric foveolar <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="12" pm="."><plain>Loss or aberrant Lgl2 staining was useful in identifying Barrett gastric foveolar <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
</text></document>